Ambrosia Bio

Enzyme-Based Bioprocess Technology for Low-Calorie Sugar Alternatives

Startup

Ambrosia Bio is a Jerusalem-based startup in the Agriculture & Food Technologies sector, established in 2020. Enzyme-Based Bioprocess Technology for Low-Calorie Sugar Alternatives . The company has raised a total of $1.52M across 8 funding rounds, currently at the Seed stage. Ambrosia Bio was founded by Ziv Zwighaft. Key investors include Undisclosed Investor(s), Brinc. The company has 1-10 employees. Core technologies: Biologicals, Molecules.

With $1.52M in total funding, Ambrosia Bio is a Seed-stage company operating in Agriculture & Food Technologies. The company follows a B2B business model. Product stage: Alpha. The company holds 1 patent.

$1.52M
Raised
8
Rounds
2
Investors
8
Team
2020
Founded
1
Patents
Sector & Technology
Agriculture & Food TechnologiesFood TechFood Trade & ServicesNovel Food & IngredientsBiologicalsMolecules
At a Glance
Investors
Founders
In the News

1 article covered by sources including european-biotechnology.com.

european-biotechnology.com · Jun 27, 2022
TWB announces winners in industrial biotech start-up contest
Read article ↗
Frequently Asked Questions
What does Ambrosia Bio do?

Ambrosia Bio has developed a disruptive enzyme technology platform that is used to design superior enzymes capable of converting obesity-promoting industrial sugars into minimal-calorie rare sugars such as Allulose. Ambrosia Bio’s B2B business model will provide the leading sugar and Food & Beverages (e.g., juice) manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. Ambrosia Bio will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging rare sugars such as Allulose demand.

How much funding has Ambrosia Bio raised?

Ambrosia Bio has raised $1.52M in total funding across 8 rounds. The company is currently at the Seed stage. Key investors include Undisclosed Investor(s), Brinc.

Who founded Ambrosia Bio?

Ambrosia Bio was founded in 2020 by Ziv Zwighaft (Co-founder & CEO).

What sector is Ambrosia Bio in?

Ambrosia Bio operates in Agriculture & Food Technologies, Food Tech, Food Trade & Services, Novel Food & Ingredients, with core technologies in Biologicals, Molecules. Target customers: Industrial Manufacturing, Agriculture & Food, Processed Foods, Beverages, Ingredients, Food Retail & Consumption.

Where is Ambrosia Bio located?

Ambrosia Bio is based in Givat Ram, Jerusalem, Israel. The company also has offices abroad.

View Full Profile Classic View Website ↗